InvestorsHub Logo
Followers 197
Posts 24669
Boards Moderated 0
Alias Born 04/03/2010

Re: manibiotech post# 693251

Wednesday, 05/22/2024 1:24:55 PM

Wednesday, May 22, 2024 1:24:55 PM

Post# of 700250
That’s the common approach. And a safety review. There are no safety issues. Disclosed numerous times, like every time they discuss the treatment. They can’t make that up if the IA said something else. Again, is your short fund intern posting or is this really you?

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News